Could ACAD go parabolic like PCYC? Who knows what pricetag Julian and Felix will accept for ACAD, $100, $125?
Still here. Too many garbage posters here to feel the need or desire to post. I'm holding as long as you Ed. If you give up, its time to toss in the towel. As others have said, price too low to sell right now. Looks like IDRA dead for a while. Trying to make money with my other investments. Loaded with ACAD waiting approval.
FDA is as corrupt as any other government agency. :) I have been burned on SRPT once, wouldn't touch t with a 10 foot pole. I still think this ends badly with no approval and stock at $2. Believe me, I'm for the kids though, hope something can be found soon.
Never listen to dopes on a MB on potential price. I can assure you, upon approval and a new $5 billion annual drug with no competition in an expanding marketplace that could be used for other indications, will be trading substantially higher and will be bought out at a price way north of here. No way Acadia does this alone, with so much potential an established pharma with the network in place must buy this. Been holding since $2.70's
Sentiment: Strong Buy
They are orchestrating the buyout. Even Adam F. knows this one is getting bought out. Read his mail bag if you haven't seen it today.
like IDRA is trust. You believe in leadership, the board, Vin, the Bakers, the science, past results, the team, the company vision. They have a compelling desire to develop a world-class pharmaceutical company. There time horizon is years, not months. Believe me the Baker's aren't here to turn a quick buck. They are in IDRA for the long-run. Me too.
last night at a Holiday Inn Express or be as "intelligent" as bio-loser to know this is a buying opportunity for IDRA. Sure, share price could drop pennies from here, not a big deal unless you are here for a flip. Long-term holders, who see the potential and trust the pipeline and management , will be the ultimate winners here. If past behavior is any indication of the future, the Baker Bros will own 15-20 million shares within two years after promising data reported . . . price will follow. Have no problem selling every other stock in my portfolio . . . will not touch my IDRA.
Sentiment: Strong Buy